|
US5206018A
(en)
*
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
IT1197485B
(it)
*
|
1986-10-07 |
1988-11-30 |
Boehringer Biochemia Srl |
Composizioni farmaceutiche ad attivita' antineoplastica
|
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
ES2219646T5
(es)
*
|
1993-02-22 |
2008-11-01 |
Abraxis Bioscience, Inc. |
Metodos para la administracion in vivo de compuestos biologicos y composiciones utiles para los mismos.
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US5665383A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6753006B1
(en)
*
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US5362478A
(en)
*
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6528067B1
(en)
*
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
EP1683517A1
(en)
|
1996-08-19 |
2006-07-26 |
American Bioscience, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
IL132094A0
(en)
*
|
1997-03-27 |
2001-03-19 |
Baker Norton Pharma |
Methods and compositions for treatment of ovarian cancer
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
KR100789008B1
(ko)
|
1997-06-27 |
2007-12-26 |
아브락시스 바이오사이언스 인크. |
신규 약물 제제
|
|
EP1171117A4
(en)
|
1999-04-22 |
2002-08-07 |
American Bioscience Inc |
LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
|
|
EP1178786A4
(en)
|
1999-05-21 |
2006-03-01 |
American Bioscience Inc |
PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
ATE406892T1
(de)
|
2001-04-06 |
2008-09-15 |
Wyeth Corp |
Antineoplastische kombinationspräparate enthaltend cci-779 (rapamycin derivat) zusammen mit gemcitabin oder fluoro-uracil
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
CA2480809A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Children's Medical Center Corporation |
Methods for inhibiting vascular hyperpermeability
|
|
US20040126400A1
(en)
*
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
WO2004052401A2
(en)
|
2002-12-09 |
2004-06-24 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
SI1585548T1
(sl)
*
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
AU2003293529A1
(en)
*
|
2002-12-16 |
2004-07-29 |
Nitromed, Inc. |
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
|
|
US20050119330A1
(en)
*
|
2003-03-17 |
2005-06-02 |
Kao Peter N. |
Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases
|
|
US20050038498A1
(en)
*
|
2003-04-17 |
2005-02-17 |
Nanosys, Inc. |
Medical device applications of nanostructured surfaces
|
|
US20050152979A1
(en)
*
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
EP1755653B1
(en)
|
2004-05-14 |
2014-12-31 |
Abraxis BioScience, LLC |
Treatment methods utilizing albumin-binding proteins as targets
|
|
CN101060831B
(zh)
*
|
2004-10-01 |
2010-06-23 |
拉姆斯科股份有限公司 |
可方便植入的缓释药物组合物
|
|
WO2006053754A1
(en)
|
2004-11-19 |
2006-05-26 |
Novartis Ag |
COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE
|
|
US8735394B2
(en)
*
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
MX383644B
(es)
*
|
2005-02-18 |
2025-03-14 |
Abraxis Bioscience Llc |
Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
|
|
CN101146514B
(zh)
|
2005-02-18 |
2013-03-27 |
阿布拉西斯生物科学公司 |
用于整合入医疗装置的疏水性改善的药物
|
|
BRPI0606282A2
(pt)
*
|
2005-03-17 |
2009-06-09 |
Elan Pharma Int Ltd |
composições injetáveis de compostos imunossupressores em nanopartìculas
|
|
US7514549B2
(en)
*
|
2005-04-16 |
2009-04-07 |
Michigan State University |
Tumor inhibition by modulating sprouty expression or activity
|
|
EP1888062A1
(en)
|
2005-05-16 |
2008-02-20 |
Novartis AG |
The use of rapamycin derivatives for the treatment and/or prevention of cardiovascular disorders
|
|
BRPI0615265A8
(pt)
*
|
2005-08-31 |
2018-03-06 |
Abraxis Bioscience Llc |
composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
|
|
JP5368093B2
(ja)
*
|
2005-08-31 |
2013-12-18 |
アブラクシス バイオサイエンス， エルエルシー |
増大した安定性を有する難水溶性薬剤の組成物および調製の方法
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
AU2006347740A1
(en)
|
2006-08-31 |
2008-03-06 |
Abraxis Bioscience, Llc |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
US20100112077A1
(en)
*
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
ITFI20060277A1
(it)
*
|
2006-11-08 |
2008-05-09 |
Giuliano Giustini |
Sollevatore per motociclette e simili, offrente mobilita' di spostamenti omnidirezionali
|
|
EP2117520B1
(en)
|
2006-12-14 |
2018-08-29 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
EP2131821B1
(en)
|
2007-03-07 |
2018-05-09 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
CA2686736A1
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension
|
|
DK2155188T3
(da)
|
2007-06-01 |
2013-11-04 |
Abraxis Bioscience Llc |
Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
US20120128732A1
(en)
*
|
2008-12-11 |
2012-05-24 |
Vuong Trieu |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
JP5725563B2
(ja)
*
|
2009-03-13 |
2015-05-27 |
アブラクシス バイオサイエンス， エルエルシー |
チオコルヒチン誘導体との組み合わせ療法
|
|
MX2011010673A
(es)
*
|
2009-04-10 |
2012-02-21 |
Abraxis Bioscience Llc |
Formulaciones de nanoparticulas y usos de las mismas.
|
|
EP3626233A1
(en)
|
2009-04-15 |
2020-03-25 |
Abraxis BioScience, LLC |
Prion-free nanoparticle compositions and methods
|
|
DK2470173T3
(en)
*
|
2009-08-25 |
2016-06-06 |
Abraxis Bioscience Llc |
Combination therapy of nanoparticle composition of the taxane and the hedgehog inhibitors
|
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
|
US8269348B2
(en)
*
|
2010-02-22 |
2012-09-18 |
Texas Instruments Incorporated |
IC die including RDL capture pads with notch having bonding connectors or its UBM pad over the notch
|
|
ES2580135T3
(es)
*
|
2010-03-26 |
2016-08-19 |
Abraxis Bioscience, Llc |
Métodos de tratamiento de carcinoma hepatocelular
|
|
KR101894689B1
(ko)
*
|
2010-03-29 |
2018-09-04 |
아브락시스 바이오사이언스, 엘엘씨 |
암의 치료 방법
|
|
KR20180050426A
(ko)
*
|
2010-03-29 |
2018-05-14 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
ES2639038T3
(es)
*
|
2010-06-02 |
2017-10-25 |
Abraxis Bioscience, Llc |
Métodos para el tratamiento de cáncer de vejiga
|
|
CA2801645A1
(en)
*
|
2010-06-04 |
2011-12-08 |
Abraxis Bioscience, Llc |
Use of nanoparticules comprising a taxane and an albumin in the treatment of pancreatic cancer
|
|
RU2016103126A
(ru)
*
|
2010-06-07 |
2018-11-22 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы комбинированной терапии для лечения пролиферативных заболеваний
|
|
US8871256B2
(en)
*
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
|
US9149455B2
(en)
*
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US9511046B2
(en)
*
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
*
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
US20140199405A1
(en)
*
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|